Publication at Third Faculty of Medicine |
2012
Abstract
The basal treatment of patients after a percutaneous coronary intervention (PCI) consists of administration of acetylosalicylic acid and thienopyridines, so called dual antiaggregation therapy. Recommended length of dual antiaggregation therapy depends on clinical situation and type of implanted stent.
During the treatment, it is necessary to take into account various co-morbidities and to often react to particular clinical situations. This review aims to make general practitioners familiar with guidelines on antiaggregation therapy after PCI and to show possible solutions in the treatment strategy in various clinical situations requiring an individualized approach